Navigation Links
Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an
Date:5/23/2013

TOKIO, 22. Mai 2013 /PRNewswire/ -- Ranbaxy Laboratories Limited (im Weiteren Ranbaxy), eine Tochtergesellschaft von Daiichi Sankyo Co., Ltd. (im Weiteren Daiichi Sankyo), gab am 22. Mai die Maßnahmen bekannt, die Ranbaxy in den letzten Jahren ergriffen hat, um sich der Angelegenheiten der vorhergehenden Unternehmensführung anzunehmen.

(http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html).

Daiichi Sankyo unterstützt Ranbaxy weiterhin dabei, die Fehler der vorhergehenden Geschäftsführung zu korrigieren, welche zu Untersuchungen durch das Justizministerium der Vereinigten Staaten und die US-Arzneimittelzulassungsbehörde („USFDA") geführt hatten. Die Änderungen, die bei Ranbaxy vorgenommen werden sollen, umfassen die Geschäftsführung, die Unternehmenskultur, den Betrieb und die Compliance.

Daiichi Sankyo geht davon aus, dass bestimmte ehemalige Aktionäre von Ranbaxy wichtige Informationen hinsichtlich der Untersuchungen durch das US-Justizministerium und die FDA verschwiegen und falsch dargestellt haben. Daiichi Sankyo prüft derzeit die verfügbaren Rechtsmittel und kann das Thema nicht weiter kommentieren.

Informationen zu Daiichi Sankyo Co., Ltd. 
Börsennotierung: Börsenkürzel: 4568, Erster Index der Börsen in Tokio, Osaka und Nagoya
Präsident und CEO: Joji Nakayama

Kontakt: 
Noriaki Ishida 
Corporate Officer & Vice President 
Abteilung für Unternehmenskommunikation
Daiichi Sankyo Co., Ltd. 
Tel.: +81-3-6225-1126 
E-Mail: kondo.toshiya.cj@daiichisankyo.co.jp

http://www.daiichisankyo.com/


'/>"/>
SOURCE Daiichi Sankyo Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA
2. Ranbaxy Commends New IMS Study Which Credits Generic Prescription Drugs With $1 Trillion Savings In U.S. Health Care Costs Over Past 10 Years
3. Ranbaxy Launches Authorized Generic Of Pioglitazone In The U.S.
4. Ranbaxy Issues Voluntary Nationwide Recall of 41 lots of Atorvastatin Calcium Tablets 10 mg, 20 mg and 40 mg Due to Potential Presence of Foreign Substance
5. Ranbaxy to Market Desvenlafaxine Base Extended Release Tablets in the U.S.
6. Indias Largest Generic Drugmaker Ranbaxy Pays $500 Million to Settle Systemic Generic Drug Manufacturing Fraud
7. Statement By Dinesh Thakur Regarding US Governments Case Against Ranbaxy
8. Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives
9. GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
10. Simbionix kündigt Lizenzvertrag für chirurgische Videos an
11. Blue Belt Technologies kündigt Gründung eines wissenschaftlichen Beirats für Hüfteingriffe zur Bestimmung neuer Anwendungsgebiete von NavioPFS bei femoro-acetabulärem Impingement an
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... ... Forecast 2016-2026: Opportunities for Leading Companies – our new ... new report discusses issues and events affecting the Alzheimer,s ... qualitative analyses to answer these key questions: - How ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... 2017 Accuray Incorporated (Nasdaq: ARAY ... continue to set the bar for excellence in customer ... user satisfaction rating among radiation treatment delivery systems in ... Market Intelligence Briefing™. The most recent ratings trend also ... industry peers for 11 of the past 12 quarters. ...
Breaking Medicine Technology:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Knowledge is ... be guided by faith. “Knowledge is God’s Lighthouse” is the creation of published author, ... cookbooks, novels, and poetry collections. , “I have been writing since high school ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Management System: an On-demand E-learning system for Clinical and Regulatory education for ... is based on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO ... the name of their drug rehab center in Delray Beach, Florida has been changed ... not only stars such as Philip Seymour Hoffman and Chris Farley are dying from ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Cosmetic ... of plastic surgery procedures in order to make it easier for their readers to ... of the body they impact as well as the techniques used on those particular ...
(Date:1/19/2017)... IL (PRWEB) , ... January 19, 2017 , ... ... N.A., announced it recently provided a new $11,250,000 senior credit facility to Sunrise, ... new MB credit facility were used to facilitate a recapitalization of MedPro led ...
Breaking Medicine News(10 mins):